The European Union's pharmaceutical sector is in a constant state of evolution. With exacting regulations, growing patient expectations, and the rapid pace of research, navigating this intricate landscape requires a prudent approach. Pharmaceutical companies must adapt to this challenges by adopting innovative technologies, partnering with key stak